secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-RAD LABORATORIES, INC. (BIO)
CIK:        0000012208
Form:       8-K
Filed at:   2026-02-19T23:59:59+00:00
Accession:  0000012208-26-000012
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Rad updates Sartorius AG 2025 financials: sales €3.54B, net profit €230M
----------------------------------------------------------------------------

- Sartorius AG 2025: sales €3,538.1M, gross profit €1,636.7M, EBIT €542.6M, net profit €230.4M.
- Balance sheet: current assets €1,766.2M, non-current €7,951.1M, total equity €3,867.2M.
- Operating cash flow €837.0M; investing outflow €513.7M; financing outflow €591.4M.
- Update follows Sartorius’ Feb 16, 2026 release; Bio-Rad’s 10-K investment disclosure updated accordingly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/12208/000001220826000012/0000012208-26-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/12208/000001220826000012/bio-20260219.htm
  HTML page:      https://secwatch.observer/filing/0000012208-26-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer